The hazard
CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, 90-count bottles (NDC 51991-747-90) Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922.
Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx Only, 90-count bottles (NDC 51991-748-90) Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922.
- Brand / company
- Breckenridge Pharmaceutical, Inc
- Codes / lots
- Lot # 222205C, exp. date 11/2025 | Lot # 230077C, exp. date 11/2025
- Distribution
- Nationwide in the US
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 1 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.